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computerized procedural preparation and distraction intervention
(Ditto) used during pediatric burn wound care in comparison to
standard practice. Methods: An economic evaluation was performed
alongside a randomized controlled trial of 75 children aged 4 to 13
years who presented with a burn to the Royal Children’s Hospital,
Brisbane, Australia. Participants were randomized to either the Ditto
intervention (n ¼ 35) or standard practice (n ¼ 40) to measure the
effect of the intervention on days taken for burns to re-epithelialize.
Direct medical, direct nonmedical, and indirect cost data during burn
re-epithelialization were extracted from the randomized controlled
trial data and combined with scar management cost data obtained
retrospectively from medical charts. Nonparametric bootstrapping
was used to estimate statistical uncertainty in cost and effect differ-
ences and cost-effectiveness ratios. Results: On average, the Ditto
intervention reduced the time to re-epithelialize by 3 days at AU$194
less cost for each patient compared with standard practice. Theee front matter & 2015 Published by Elsevier Inc.
(ISPOR).
.1016/j.jval.2015.04.011
st: One of the supervisors of the trial, Roy M. Kim
t stand to lose or gain ﬁnancially or personally
incipal researcher has no ﬁnancial interest in the
wn@uqconnect.edu.au.
ondence to: Nadia J. Brown, Centre for Children’
Level 4, Foundation Building, Royal Children’s Hoincremental cost-effectiveness plane showed that 78% of the simu-
lated results were within the more effective and less costly quadrant
and 22% were in the more effective and more costly quadrant,
suggesting a 78% probability that the Ditto intervention dominates
standard practice (i.e., cost-saving). At a willingness-to-pay threshold
of AU$120, there is a 95% probability that the Ditto intervention is
cost-effective (or cost-saving) against standard care. Conclusions:
This economic evaluation showed the Ditto intervention to be highly
cost-effective against standard practice at a minimal cost for the
signiﬁcant beneﬁts gained, supporting the implementation of the
Ditto intervention during burn wound care.
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nonpharmacological intervention, randomized controlled trial, re-
epithelialization.
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It is estimated that more than 500,000 children worldwide are
hospitalized with a burn injury every year [1]. Burn care is
undeniably expensive and arguably has one of the highest
ﬁnancial costs in pediatric health care, yet limited health eco-
nomic research has been conducted in the burns arena. External
ﬁnancial pressures on health care budgets create much deliber-
ation and contentious debates over balancing quality health care
versus less costly service delivery [2]. There is a great need for
health research to extend beyond providing evidence of onepractice being more effective than another. Changes in practice
need to be quantiﬁed in monetary terms with an economic
evaluation to determine the feasibility of implementing new
cutting-edge treatments and interventions [3] and to justify setup
costs to hospital administrators. Psychosocial costs to the patient
include the pain, anxiety, and stress from the trauma of the burn
injury itself and the associated wound care procedures and may
encompass additional psychosocial issues resulting from the
physical disﬁgurement of hypertrophic scarring. Severity of
injury does not predict psychological costs to the patient [4]. No
quality-of-life measure has been speciﬁcally developed andon behalf of International Society for Pharmacoeconomics and
ble, holds options with Diversionary Therapy Technologies (DTT);
from the results during the clinical trial period and the time of
Ditto device or DTT.
s Burns and Trauma Research, Queensland Children’s Medical
spital, Brisbane, QLD 4029, Australia.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 6 3 1 – 6 3 7632validated for the pediatric burn population [3,5]. Financial
accountability that extends beyond acute wound care and scar
management and includes the complete long-term psychosocial
costs to the patient makes the “true” costs of burns
unquantiﬁable.
The most comprehensive cost-effectiveness analysis identi-
ﬁed in the burn literature was a prospective study over a 5-year
period conducted in the Burn Centre of Valencia, Spain [6]. This
study incorporated incremental cost-utility ratio analysis to
determine the cost and quality of life of burn patients. This cost
analysis largely depended on Diagnostic Related Groups, used
silver sulfadiazine in the treatment of burn wounds, and was
carried out for primarily an adult inpatient population with a
mean age of 40 years and mean total body surface area (TBSA)
burns of 18.2%. General Diagnostic Related Group and Healthcare
Resource Group cost coding provide a generic snapshot of costs
and are not sensitive measures for picking up differences across
individuals [7].
Two studies were identiﬁed in the burn literature that per-
formed a cost-effectiveness evaluation on minor burns encom-
passing smaller TBSA (mean r10%) and primarily partial-
thickness depth [8,9]. Both studies compared burn dressings,
which are not standard practice in burn centers in developed
countries. Advances in the technology of burn dressings in recent
years have changed standard practice from twice-daily applica-
tions of silver sulfadiazine and similar ointments or creams to
improved silver-impregnated dressings such as Acticoat [10]. This
change in practice has seen a shift from inpatient to outpatient
management of the small partial-thickness burn injury, in which
dressings are changed every 3 to 7 days. No economic evaluation
has been performed in pediatric burn outpatients that uses
advanced silver-impregnated dressings only, or that uses vali-
dated measures of re-epithelialization and wound depth.
This study aimed to establish the cost-effectiveness of a
computerized procedural preparation and distraction interven-
tion Ditto, which was compared with standard practice, in a
randomized controlled trial (RCT) measuring burn re-
epithelialization [11]. Use of virtual reality and computerized
nonpharmacological interventions plays a signiﬁcant role in
dampening pain perception when used as an adjunct to pharma-
cological intervention during burn care and rehabilitation [12–21].
Several studies report on the effect of stress in delaying wound
healing [22–29], and cellular links between pain and delayed
wound healing are beginning to be explored [30]. The risk of
hypertrophic scar formation is known to increase when wound
re-epithelialization extends beyond 14 days [31,32]. Accelerating
re-epithelialization is the prime objective of burn care, and has
signiﬁcant cost beneﬁts to the health system and the patient.Methods
Setting and Participants
Data were collected from the Stuart Pegg Paediatric Burns Centre
at the Royal Children’s Hospital, Brisbane, which is a tertiary
pediatric burn referral center servicing approximately 800 new
patients per year. Data collection occurred in two parts: 1) RCT
[11,33] data collected from August 2011 to August 2012 and 2)
retrospective review of medical charts from August 2011 to
September 2013 to obtain scar management data 12 months after
re-epithelialization (Fig. 1). Children were included if they were
aged 4 years to 13 years and had an acute burn injury of TBSA
less than 15%. Children were ineligible if they were non-English
speaking, had a diagnosed condition or illness in addition to a
burns injury, or had a history of suspected child abuse. On the
ﬁrst dressing removal, further study eligibility was determined(because of the inability to predict patient and wound manage-
ment needs when wounds are covered on consent) including the
following: erythema only, skin graft required, use of Entonox. The
standard medical treatment received by patients was not altered
by study participation. The Queensland Children’s Health Serv-
ices (Royal Children’s Hospital) Human Research Ethics Commit-
tee and The University of Queensland Ethics Committee
approved this RCT and it was registered with the Australian
New Zealand Clinical Trials Registry (ACTRN12611000913976).Interventions
Administrative staff external to the study used a portable
computerized random number generator to randomly assign
participants to one of two groups: 1) to receive the Ditto
intervention [34], consisting of a computerized multimodal
device delivering the procedural preparation in the waiting room,
and then the distraction intervention during wound care proce-
dures; or 2) to receive standard preparation and standard dis-
traction (such as videos, books, toys, television, and/or parental
soothing).Data Collection
Part 1. Prospective data collection: RCT
Recruitment and consent of participants occurred at the ﬁrst
change of dressing, where burn wounds were scanned with the
Moor LDI2-BI2 laser Doppler imager (Moor Instruments Limited,
Devon, UK) to measure burn depth, enabling accurate wound
comparison across participants. Additional clinical characteris-
tics collected included the following: mode of burn, TBSA of burn,
site of burn, ﬁrst aid administered, and skin tone. Visitrak grids
(Smith þ Nephew, London, UK) were used at every dressing
change to determine the percentage of wound re-epithelializa-
tion, the primary outcome measure of the RCT. Visitrak was the
chosen measure of re-epithelialization for this study (over
blinded reviewers determining the percentage of re-
epithelialization from photos taken at every dressing change
[11]) due to Visitrak’s valid and reliable wound measurement
technique [35,36] using mathematical calculations rather than
clinical judgment. Clinical cost data collected at every dressing
change until burn re-epithelialization included the following:
dressing type (primarily Acticoat or Acticoat 7, with or without
Mepitels) determined by consultant clinical judgment, and
quantity of dressings applied; pharmacological pain relief admin-
istered (narcotic [oxycodone opioid, 0.1–0.2 mg/kg]; narcotic
combined [oxycodone and either paracetamol or ibuprofen; or
codeine and paracetamol]; or non-narcotic analgesia [paraceta-
mol and/or ibuprofen]); and nursing and consultant time taken
per patient.
Caregivers completed a general demographic questionnaire
(including pertinent cost-related questions regarding transport,
parking, days off work due to attending burn center appoint-
ments, employment beneﬁts received, highest education level,
employment status, family income per annum, and postcodes to
establish socioeconomic status [using Socio-Economic Indexes
for Areas] [37]).Effect Estimation
The number of days from injury until more than 95% re-
epithelialization was used as a measure of the intervention
effect. Minimizing the number of days to re-epithelialize reduces
the likelihood of hypertrophic scarring [31,32,38] and therefore
may reduce the cost to the health system and the patient.
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Re-epithelialization 
Consented & Randomized 
(n = 117) 
* Standard group 
(n = 62) (n = 55) 
** Standard group 
(n = 40) 
 group 
(n = 35) 
*** Standard group 
(n = 19) 
 group 
(n = 9) 
Received scar 
management 
(n = 11) 
Received scar 
management 
(n = 6) 
Dressing Changes
Change of Dressing 1
* Participants consented and randomized  in the burn center waiting room prior to dressing removal
** 
occurring concurrently; early discharge to local regional hospital
*** Assessed for scar management (re-epithelialization >14 days)
Fig. 1
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All data during the re-epithelialization phase of healing were
collected prospectively at every dressing change from the health
care provider and participant perspectives. Direct health care
costs included the following: administered narcotic medication;
size, type, and quantity of dressings; nursing time to remove and
apply dressings; and consultant review time. Nursing wages were
based on 2012 Queensland Health Clinical Nurse Grade 6 with a
standard (for Queensland Health employees) addition of 25.85%
on-costs [39]. Consultant wages were based on 2012 Queensland
Health Medical Ofﬁcer Level 2 (Staff Specialist Level 26) with
25.85% on-costs added [40] (see Appendix A in Supplemental
Materials found at: http://dx.doi.org/10.1016/j.jval.2015.04.011).
Direct non–health care costs included travel and hospital parking
costs. Families were asked about their mode of transport and
time spent traveling, and distances traveled to and from appoint-
ments by each patient were calculated via postcodes. Travel costs
were calculated on the basis of Royal Automobile Club of Queens-
land estimates of running a medium-size car to be AU$0.76/km
[41]. Postcodes were also used to determine public transport
zones to establish travel costs. Indirect non-health care costs of
caregiver(s) days off work were documented at every dressing
change, and used together with their annual family income
bracket (recorded on the participant demographic questionnaire)
to establish time costs. Annual family income was estimated by
calculating the arithmetic mean of the lower and upper limits of
reported income bracket, of which there were four. In addition,
income data from the Australian Bureau of Statistics household
income distribution for Queensland in 2011 to 2012 [42] were used
to establish overall minimum and maximum limits, such that
means of the lowest and highest brackets could be calculated.Part 2. Retrospective data collection: Scar management costs
At 1 year after re-epithelialization of the last participant, a
retrospective review of charts was conducted to establish
whether scar management intervention was received. As a
standard guideline, at the 12-month scar management review,
therapists are able to determine whether scar management is
having an effect and whether further scar management is
warranted. The costs associated with each individual patient’s
scar management intervention that occurred beyond 12 months
were based on estimations by the treating occupational therapist.
If patient charts reported the prescription of standard and/or
customized pressure garments, patient order form records were
obtained to establish exact costs. Documented use of silicone
moulds alongside pressure garments was included in direct
health care costs on the basis of product cost and occupational
therapist’s estimation of average moulds made per tub. Tubigrip
product costs were used and amounts given were estimated on
the basis of the age of the child and the TBSA of burn. Doc-
umentation of prescribed silicone products including Kelo-cote
cream and Mepiform sheets, together with standard prescribing
practices within the burn center, was used to calculate amounts
and costs of these products. The individual patient’s hospital
record number was used to track the exact cost for steroid
injections received. Occupational therapy scar management
appointments are a standard 30 minutes. Scar management staff
costs were calculated on the basis of documented therapy
appointments (using 2012 Queensland Health, Health Professio-
nal Level 4 wage rate and 25.85% on-costs added [43]; Appendix
A). Consultant reviews following scar management were based
on an estimated average of 15-minute appointments (and wages
were based on Queensland Health Medical Ofﬁcer Level Two,
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 6 3 1 – 6 3 7634MO2/L26, with 25.85% on-costs added [40]). Direct non–health
care costs included travel to and from documented scar manage-
ment appointments and parking costs (extrapolated from RCT
data of parent-reported travel). Indirect non–health care costs of
parental wages lost were estimated on the basis of data collected
from parental reports of time spent during the previous hospital
visits for burn dressing changes.
Statistical Analysis
Analyses were carried out with a complete case data set for the
primary outcome of re-epithelialization. When children had more
than one burn, days to re-epithelialization were based on the
deepest burn (determined by the laser Doppler imager depth
variable). Thus, a new day to re-epithelialize variable was
generated to identify health care costs per patient, not per burn.
Missing data from cost variables were inputted using mean
imputation. Demographic and clinical characteristics across
groups were compared with chi-square tests or t tests for
normally distributed data and Mann-Whitney U tests when
variables were not normally distributed. Incremental cost-
effectiveness ratios (ICERs) were calculated from the ratio of
mean cost differences between the two groups (the Ditto inter-
vention and standard practice) divided by the difference in effect
of days taken for burns to re-epithelialize. Nonparametric boot-
strapping was performed using 10,000 iterations, which achieved
convergence of the standard error and a stable estimate of the
variance of the ICER. This statistical method uses large numbers
of simulated sample data to calculate the uncertainty around the
sampling distribution of the cost and effect estimates [44]. A cost-
effectiveness plane and cost-effectiveness acceptability curve
were used to display the results. Sensitivity analysis was per-
formed to test the robustness of the results. One-way sensitivity
analysis was conducted on all probabilities and ratios by varying
one variable at a time; these included removing the steroid
injection variable because only one patient underwent this treat-
ment as well as removing the Ditto variable and testing an
alternate Ditto Lite variable, the newest version of the Ditto that
came on the market after the RCT had commenced. A 3%
discount rate was applied to all costs that extended beyond a
period of 1 year [6] to calculate costs in 2012 Australian dollars.
Summary statistics of data not normally distributed were
reported in median and interquartile ranges, rather than as
means and SDs. The statistical analyses were conducted using
the Stata statistical software package (StataCorp, College Station,
Texas) [45] and Excel 2010 (Microsoft Pty. Limited, North Ryde,
NSW, Australia).Results
One hundred seventeen children presenting to the Burn Centre
met the eligibility criteria and consent for participation was
obtained. At the second stage of eligibility screening (establishing
patient and wound management needs), 42 participants were
found to be ineligible. Five patients were lost to follow-up, and
three patients were discontinued because of the inability to
collect data on multiple participants at the same time. A total
of 75 children were included in the analysis (Fig. 1), 40 in the
standard group and 35 in the Ditto group. Baseline demographic
and clinical characteristics were comparable across groups
(Table 1). The sample was typical of our outpatient burn pop-
ulation, with most of the patients being male (60% standard
group, 57% Ditto group), presenting with a partial-thickness burn,
and a higher proportion of scalds as the mechanism of injury
(55% standard group, 51% Ditto group). Only two variables were
missing from the primary outcome variable, days to re-epithelialize. On average, the cost for a typical pediatric burn
outpatient presenting with a superﬁcial partial-thickness burn
who receives standard care (Table 2) is approximately AU$1000.
Refer to Appendix A for unit costs.
Clinical Outcome
Children who received the Ditto procedural preparation and
distraction intervention during burn wound care procedures re-
epithelialized on average 3 days faster (P ¼ 0.033) than children in
the standard practice group (Table 2). This reduction in re-
epithelialization time translated to a smaller number of children
requiring scar management in the Ditto group. In the standard
practice group, 19 (47.5%) children re-epithelialized in 14 or more
days and were therefore assessed for scar management, of which
11 (27.5%) went on to receive the scar management intervention.
Nine (25.7%) children in the Ditto group re-epithelialized in 14 or
more days and were assessed for scar management. Six (17.1%)
of these children went on to receive the scar management
intervention. Three of these participants continued to receive
the scar management intervention beyond 1 year after re-
epithelialization.
Cost-Effectiveness Analysis
On average, direct health care costs, direct non–health care costs,
and overall costs per child were lower in the Ditto group (Table 2).
The standard group had, on average, lower indirect non–health
care costs (Table 2). Parents of children in the standard group
reported fewer days off work taken to attend appointments, with
the number of work days missed by fathers being signiﬁcantly
less (standard group mean ¼ 0.16 days, Ditto group mean ¼ 1.2
days, P o 0.001) in the standard group than in the Ditto group.
The mean total cost of direct health care per patient was AU
$475  A$1073 in the standard group, compared with AU$185 
$200 in the Ditto group (Table 2). Itemizing the direct health care
costs, the highest percentage of cost was for customized pressure
garments for the standard group and burn dressings for the Ditto
group (see Appendix A). Cost differences are explained in the
reduction in days for burns to re-epithelialize, which translated
to fewer patients in the Ditto group requiring the scar manage-
ment of pressure garments, silicone products, and steroid
injections.
Comparing the Ditto intervention against standard care on a
cost-effectiveness plane showed that 77.6% of the cost/effect
pairs were within the southeast quadrant (Fig. 2). This is a strong
indication that the Ditto intervention is more effective and costs
less than standard care (i.e., cost-saving). The percentage of
incremental cost/effect pairs located in the northeast quadrant,
indicating that the Ditto intervention is more effective and more
costly, was 21.6%. The point estimate gave us a base-case
incremental cost of –AU$194 per child, with a mean incremental
effect of 3 days reduction to re-epithelialize. The mean ICER was
dominant (95% uncertainty interval ¼ dominant to AU$207) for
every 1-day reduction in days to re-epithelialize when children
had access to the Ditto intervention, over standard practice
(Table 3). The cost-effectiveness acceptability curve shows that
the probability of the Ditto intervention being cost-effective (or
cost-saving) would be 95% if the willingness-to-pay threshold
were AU$120 per 1-day reduction in re-epithelialization (Fig. 3).
Sensitivity analysis conﬁrmed that the results were robust.
The inﬂuence of the outlying high cost of steroid injections,
received by only one patient in the standard care group as a scar
management intervention, was tested by removing the cost from
the analysis. Comparable results were obtained in this sensitivity
analysis (see Appendix B in Supplemental Materials found at:
http://dx.doi.org/10.1016/j.jval.2015.04.011). In addition, the cost
Table 1 – Demographic and clinical characteristics.
Characteristic Standard group (n ¼ 40) Ditto group (n ¼ 35) P
Age (y), mean SD 7.8  4.79 8.1  4.77 0.683*
Sex, n (%)
Male 24 (60) 20 (57) 0.802†
Female 16 (40) 15 (43)
Ethnicity, n (%)
Caucasian 32 (80) 32 (91) 0.393†
Non-Caucasian 8 (20) 3 (9)
Family income (A$), n (%)
o26,000 9 (24) 5 (15) 0.718†
26,000–$67,500 6 (16) 8 (24)
67,500–$115,000 13 (34) 12 (36)
4115,000 10 (26) 8 (24)
SEIFA, n (%)
High 4 (10) 4 (11.5) 0.949†
Medium 14 (35) 13 (37)
Low 22 (55) 18 (51.5)
Mechanism, n (%)
Scald 22 (55) 18 (51) 0.601†
Contact 12 (30) 12 (34)
Flame 1 (2.5) 3 (9)
Friction 4 (10) 2 (6)
Chemical 1 (2.5) 0 (0)
Depth (PU), mean  SD
Mean PU of burn area 1107.02  299.30 1113.79  291.87 0.418*
Deepest PU in burn area 598.09  182.32 605.92  120.81 0.850*
PU, perfusion units of blood ﬂow (laser Doppler images measuring burn depth); SEIFA, Socio-Economic Indexes for Areas.
* t test.
† chi-square.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 6 3 1 – 6 3 7 635of the newest version of the intervention device, the “Ditto Lite,”
was analyzed and yielded very similar results to the original
results (Appendix B). The cost-effectiveness plane showed that
78% of the cost/effect pairs were within the southeast quadrant
and 21% in the northeast quadrant.Discussion
This is the ﬁrst comprehensive economic evaluation that exam-
ined the cost-effectiveness of a nonpharmacological interventionTable 2 – Costs and outcomes of providing the Ditto inter
re-epithelialization and scar management.
Costs Standa
Total direct health care cost
Direct health care cost per child, mean  SD 475
Total direct non–health care cost
Direct non–health care cost per child, mean  SD 296
Total indirect non–health care cost
Indirect non–health care cost per child, mean  SD 268
Total cost for therapy group
Total cost per child, mean  SD 1040
Outcome
Days to re-epithelialize 14.5
Note. Values are in Australian dollars (A$).
CI, conﬁdence interval.
* Mann-Whitney test.targeting a pediatric burn outpatient population. The Ditto device
intervention resulted in a substantial gain, hastening burn
wound re-epithelialization [33], conﬁrming the results of a pre-
liminary study [19]. Despite the initial outlay cost for the Ditto
device, when considered against the effects, intervention was
found to be more effective and less costly than standard care. The
beneﬁts greatly outweigh the costs, with 77% of the cost/effect
pairs falling in the more effective and less costly southeastern
quadrant.
The speed of burn re-epithelialization is paramount for the
patient [46] and the health system. A reduction of 3 days couldvention and standard care to participants during burn
rd group costs Ditto group costs P
19,003.38 6,483.64
.08  1073.45 185.25  199.96 0.531*
11,856.77 8,287.92
.42  291.30 236.80  193.96 0.454*
10,753.44 14,830.88
.84  369.84 423.74  551.56 0.196*
41,613.59 29,602.44
.34  1410.32 845.78  661.09 0.694*
Mean (CI) Mean (CI) P
(12.19–16.81) 11.5 (10.26–12.82) 0.094*
Fig. 2 – AU$, Australian Dollars. Fig. 3 – AU$, Australian Dollars.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 6 3 1 – 6 3 7636mean a burn re-epithelializes within 10 to 14 days of injury, with
decreased risk of hypertrophic scar development [31,32]. This
may reduce the burden of injury for the patient in terms of
psychological and psychosocial implications commonly accom-
panying burn scarring [4] and for the health system, with regard
to costs associated with scar management and rehabilitation.
The mean direct health care cost per patient for the Ditto
group was AU$185, compared with AU$475 in the standard
practice group (Table 2). Limited comparisons can be made with
other studies due to the minimal economic evaluations that have
been conducted in the area of burn injuries. Of the few studies
investigating the cost of burns, the foci have been on inpatient
stays and more severe burn injuries requiring grafting and often
multiple surgeries [47–51]. These studies are either retrospective
reviews or cost analyses that relied on codes of Diagnostic
Related Group. Analysis of costs based on hospital charges often
grossly overestimate costs [47].
Hospitalizations in Australia resulting from burn injuries, in
comparison to the population, were reported to equate to 47.9
cases per 100,000 population per year (based on data collected
during the period 1999 to 2004) [52]. In 2000, the hospital costs of
burns were estimated to be between AU$38.7 million and A$40.2
million per year [52]. The shift in practice of treating superﬁcial to
deep partial-thickness burn injuries predominately on an out-
patient basis, together with standard recording of burn data
when patients are admitted for longer than 24 hours only [53],
highlights that collected burn data represent only a fraction of all
pediatric burn injuries treated at Australian and New Zealand
burn centers. The burden of burn injuries to the health system
and patients is undeniably signiﬁcant, and this study is the ﬁrst
to report on burn outpatient costs.
The strengths of this study include the individualized cost
data collected on each patient, the valid measures used in theTable 3 – Incremental cost-effectiveness results.
Incremental outcomes Mean 95% UI
Incremental cost 194 733 to 243
Incremental effect 2.95 0.57 to 5.54
ICER Dominant Dominant to 207
Note. Values are in Australian dollars (AU$).
ICER, incremental cost-effectiveness ratio; UI, uncertainty interval.assessment of re-epithelialization and burn depth, and the
statistical analyses conducted to account for the uncertainty of
the ICER of a nonpharmacological intervention in pediatric burn
outpatients. A limitation of this study is the small sample size;
unequal increments of annual family income brackets used in
the parental questionnaire to collect indirect non-health care
cost data; and the fact that parental days off work to attend
appointments did not consider shift work, full-time mothers, and
parents on annual leave. The accuracy of indirect non-health
care costs may be improved in future studies with narrower
ranges and equal distribution brackets of annual family income.
Second, the scar management data were retrospectively col-
lected. Order forms of specialized custom-made pressure gar-
ments were obtained, enabling exact costs to be established, and
standard 30-minute scar management appointments enabled
occupational therapy staff costs to be calculated. The accuracy
of costing for silicone products, however, relied on accurate
documentation, and product amounts were estimated on the
basis of the size of the burn and occupational therapy protocols.
Burn care is resource intensive and requires specialist care [3].
With the challenge of health care budget constraints and the
complexity of burn care, justifying the inclusion of cutting-edge
treatments and interventions within a specialist burn center
requires comprehensive economic evaluations to be undertaken.
The inclusion of wound care management, scar management,
psychosocial, and quality-of-life measures in future economic
evaluations is warranted to establish quality and cost-effective
practices.
Source of ﬁnancial support: The randomized controlled trial
was supported by a grant given to the Royal Children’s Hospital,
Brisbane, by Diversionary Therapy Technologies (DTT). Despite
this ﬁnancial support, DTT had no role in the study design, data
collection, and analysis of this project, nor will it have any
involvement in the publication of results. The principal
researcher received a scholarship from the Centre for Children’s
Burns and Trauma Research to complete this economic
evaluation.Supplemental materials
Supplemental material accompanying this article can be found in
the online version as a hyperlink at http://dx.doi.org/10.1016/j.
jval.2015.04.011 or, if a hard copy of article, at www.valueinhealth
journal.com/issues (select volume, issue, and article).
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